Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Chem. Pharm. Forschungs-Gesellschaft describes COX-2 inhibitors

May 26, 1997

Antibodies to interferon gamma alone and in combination for arthritis and SLE

May 22, 1997

Mylan receives FDA approval for generic etodolac

May 22, 1997

Chiroscience prepares new class of peptidyl MMP and TNF-alpha inhibitors

May 22, 1997

MMP/TNF/CD23 inhibitors prepared by Chiroscience

May 21, 1997

NSAIDS reported by P&G

May 20, 1997

Antiinflammatory imidazolyl compounds from Searle

May 20, 1997

AutoImmune reports preliminary results from phase II trials of Colloral

May 14, 1997

Tularik receives U.S. patent relating to enzyme associated with inflammation

May 14, 1997

Panax to acquire CorBec

May 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...